Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 1250.00 | 252.38 | 11043.00 | 10853.00 | 1.0175 | 1.0064 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 592.00 | 817.25 | 0.7244 | 0.5757 |
| MCF 10A | Erlotinib | 10 | uM | 7 | 625.00 | 98.92 | 382.00 | 6877.50 | 0.0555 | 0.2471 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 833.00 | 817.25 | 1.0193 | 1.0284 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1409.00 | 1780.00 | 0.7916 | 0.6882 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3415.00 | 3812.75 | 0.8957 | 0.8497 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 907.00 | 817.25 | 1.1098 | 1.1602 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 625.00 | 270.29 | 817.00 | 712.50 | 1.1467 | 1.2056 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 625.00 | 98.92 | 6877.00 | 6877.50 | 0.9999 | 1.0000 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 302.00 | 312.00 | 0.9680 | 0.9372 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 832.00 | 817.25 | 1.0180 | 1.0266 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 625.00 | 98.92 | 448.00 | 6877.50 | 0.0651 | 0.2800 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 2500.00 | 469.42 | 10609.00 | 10345.25 | 1.0255 | 1.0113 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 315.00 | 312.00 | 1.0096 | 1.0188 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 341.00 | 312.00 | 1.0929 | 1.1819 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 248.00 | 312.00 | 0.7949 | 0.5973 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 469.42 | 10945.00 | 10345.25 | 1.0580 | 1.0254 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 300.00 | 312.00 | 0.9615 | 0.9246 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 610.00 | 817.25 | 0.7464 | 0.6110 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 368.00 | 312.00 | 1.1795 | 1.3509 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 357.00 | 312.00 | 1.1442 | 1.2821 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 145.00 | 119.50 | 1.2134 | 1.5890 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 209.00 | 312.00 | 0.6699 | 0.3509 |